Related Experiment Video
Updated: Jun 25, 2026

Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR
Published on: July 22, 2012
Rotavirus overview
1Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45229, USA. David.Bernstein@cchmc.org
Insights
Rotavirus gastroenteritis significantly impacts children globally, causing severe illness and high healthcare costs. Vaccination is the most effective public health strategy to prevent rotavirus infection and reduce hospitalizations.
Area of Science:
- Public Health
- Infectious Diseases
- Pediatrics
Background:
- Rotaviral gastroenteritis is a leading cause of severe diarrhea and hospitalization in young children worldwide.
- It affects nearly all children by age five, resulting in substantial healthcare expenditures.
- Current treatments are supportive, as no specific antiviral therapies exist.
Purpose of the Study:
- To highlight the public health burden of rotaviral gastroenteritis.
- To emphasize the importance of vaccination as a primary prevention strategy.
- To review the efficacy of current rotavirus vaccines.
Main Methods:
- Literature review on rotavirus epidemiology and disease burden.
- Analysis of rotavirus gastroenteritis symptoms and diagnostic challenges.
- Evaluation of rotavirus vaccination impact on disease incidence and healthcare utilization.
Main Results:
- Rotavirus infection leads to significant hospitalizations and costs, particularly in the United States.
- Improved sanitation and oral rehydration have limited impact on disease prevalence.
- Current rotavirus vaccines effectively reduce disease severity, emergency visits, and hospitalizations.
Conclusions:
- Rotavirus vaccination is the most effective intervention for preventing rotaviral gastroenteritis.
- Vaccination is now a standard part of infant immunization schedules in the United States.
- Widespread rotavirus vaccination is crucial for reducing the global burden of this disease.
Abstract:
Rotaviral gastroenteritis is a serious public health problem in both developed and developing countries. The disease is ubiquitous, affecting nearly all children by the age of 5 years. It is the most common cause of hospitalizations for gastroenteritis among children in the United States (30%-70% depending on the season) and is associated with direct and indirect costs of approximately $1 billion per year. Symptoms of rotaviral gastroenteritis are nonspecific (ie, diarrhea, vomiting, and fever), with disease severity varying considerably. Diagnostic confirmation of rotaviral gastroenteritis requires laboratory tests (most commonly enzyme immunoassay or latex agglutination); however, because specific diagnosis is costly and does not affect treatment, laboratory tests are generally not performed. Because no antiviral therapies are currently available, treatment of rotavirus infection is supportive and primarily aimed at the replacement of fluid and electrolyte losses. Based on the observations that improved sanitation does not decrease disease prevalence and that hospitalizations remain high despite the availability and use of oral rehydrating solutions, the primary public health intervention for rotavirus infection is vaccination. Current vaccines (ie, RotaTeq, Merck and Company; Rotarix, GlaxoSmithKline) are effective for reducing rotaviral gastroenteritis (particularly severe disease), emergency department visits, and hospitalizations. Rotavirus vaccination is now included as part of the routine vaccination schedule for all infants in the United States.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Size and Structure of Viral Genomes
Bacterial Gastroenteritis
Poliomyelitis
Respiratory Syncytial Virus Disease

